Today on DrugResearcher.com   Merck turns to India for latest R&D partnership Cystatin C can wash away Alzheimer's plaques Kids' vaccine market set to quadruple Simultaneous measurement of multiple cytokines Cancer antibody marches on quoths Raven Biotechnologies

Related Industry News   Blast at Aesica London plant Formulation tech goes Enterion South Africa 'underutilised' for clinical trials Researcher recognised for studies in drug delivery

Breaking News on Drug Discovery
Daily  Tuesday 20 November 2007		Forward to a colleague

	Sponsored Link ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories Merck turns to India for latest R&D partnership Merck & Co. has turned to India's Nicholas Piramal (NPIL) for its latest research collaboration, as the preclinical offshoring trend persists... Read Cystatin C can wash away Alzheimer's plaques Scientists have discovered that a protein called cystatin C can prevent damaging Alzheimer's plaques from forming by keeping their constituent protein water soluble... Read Kids' vaccine market set to quadruple A recent report suggests that the market for paediatric and adolescent vaccines is set to grow four-fold over the next decade, spearheaded by Wyeth's Prevnar as the first blockbuster vaccine... Read Simultaneous measurement of multiple cytokines Researchers at Randox, UK, have developed a biochip that enables the simultaneous measurement of 12 human cytokines from human serum samples enabling cytokine studies to be conducted faster... Read Cancer antibody marches on quoths Raven Biotechnologies Raven Biotechnologies have announced positive initial clinical trial results for their anticancer antibody that causes tumour cells to swell up and die... Read
	All News Headlines for: November | October | September
	Product Presentation ZIC®-HILIC Separation of Polar and Hydrophilic Compounds The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here
	Related Industry News Blast at Aesica London plant Contract manufacturer Aesica has confirmed reports of a blast at its Ponders End facility in North London last niight, hospitalising three workers... Read Formulation tech goes Enterion The Enterion capsule is quickly becoming big pharma's new best friend as the technology helps drug companies assess the feasibility of oral modified release formulations... Read South Africa 'underutilised' for clinical trials While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a prominent... Read Researcher recognised for studies in drug delivery Dr Mitsuru Hashida is hoping his studies into drug delivery will be useful for the pharmaceutical industry... Read Weekly Comment FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines Pfizer saves Coley with $164m buyout After a clinical hiccough five months ago set Coley Pharmaceutical's drug development funding back several years, Pfizer has stepped in to save the day, snapping up the biotech for $164m... Read Pipeline match following Celgene's $2.9bn acquisition of Pharmion Celgene has agreed to pay $2.9bn for Pharmion in the hope of becoming a 'global leader in the haematology and oncology field', but do the company's pipelines match up well together?... Read Caliper launches combo drug testing services Caliper Life Sciences has launched new testing services that will help researchers weed out unsuitable combination drug therapies in the preclinic... Read Russia's clinical biz showing signs of recovery after biologics ban Russia's clinical trials industry appears to be making a gradual recovery from a setback earlier this year when the government imposed an unexpected ban on biologic exports... Read Icahn invests in Genzyme, prompts takeover rumours The man often credited with causing Biogen Idec to be put up for sale, billionaire corporate raider Carl Icahn, has invested in Genzyme and promptly started industry tongues wagging about a takeover... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com